Insights On Drug Development

  1. EMA Support For Rare Disease Therapies 6/10/2025

    Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

  2. The Role Of A Consulting Firm In The IND Process 6/10/2025

    Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

  3. Choosing The Right PBMCS For Your Research And Product Development Needs 6/10/2025

    Enhance the success of your research and cell therapy programs by sourcing PBMCs with proven functional performance and donor-specific insights.

  4. Flow Chemistry Vs. Batch Processes 6/10/2025

    Explore how continuous flow chemistry can accelerate your chemical development with greater efficiency, safety, and sustainability compared to traditional batch processes.

  5. Linking Clinical Correlates To Cell Therapy Outcomes 6/9/2025

    Streamline cell therapy development by transforming complex cellular characteristics into a predictive, multiparametric metric that guides the selection of high-potential starting material.

  6. Injection Site Reaction Screening Methodology 6/6/2025

    Optimize drug formulations for solubility at physiological pH to reduce injection site reactions, enable high-concentration dosing, and enhance patient comfort and compliance.

  7. Part Three: Rapid LVV Titering Determination 6/6/2025

    Explore how a platform compares data to traditional qPCR, p24 ELISA, and TU assays in measuring both physical and functional titers.

  8. Part Two: Overcoming Limits In LVV Titer Measurement 6/6/2025

    Learn how a platform streamlines LVV titer measurement, offering a faster and more efficient alternative to traditional methods and addressing key process development challenges.

  9. Part One: Challenges In LVV Purification And Quantitation 6/6/2025

    Discover how a company is overcoming purification challenges and advancing scalable, GMP-ready LVV manufacturing for gene and cell therapies.

  10. Navigating OOX Results: Effective Analysis, Management In CDMO Labs 6/5/2025

    By prioritizing the management of Out of Expectation (OOX) results within your CDMO laboratory, learn how you can ensure product integrity, patient safety, and unwavering regulatory compliance.